See more : Bridgetown Holdings Limited (BTWNU) Income Statement Analysis – Financial Results
Complete financial analysis of Ucommune International Ltd (UK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ucommune International Ltd, a leading company in the Real Estate – Services industry within the Real Estate sector.
You may be interested
- Professional Computer Technology Limited (6270.TWO) Income Statement Analysis – Financial Results
- SK Rent A Car Co., Ltd (068400.KS) Income Statement Analysis – Financial Results
- ITL Industries Limited (ITL.BO) Income Statement Analysis – Financial Results
- MBK Co.,Ltd. (3121.T) Income Statement Analysis – Financial Results
- Monex, S.A.B. de C.V. (MONEXB.MX) Income Statement Analysis – Financial Results
Ucommune International Ltd (UK)
About Ucommune International Ltd
Ucommune International Ltd manages and provides agile office spaces in China and internationally. It operates self-operated and asset-light models. The company also provides individual services, such as catering, fitness, healthcare, training, and entertainment; general corporate services, such as corporate secretary, human resources, legal, finance, IT support, and tax services; incubation and corporate venturing services; design and build services; advertising and branding services; and related services. It serves individuals and enterprises. The company operates under the Ucommune brand. Ucommune International Ltd was founded in 2015 and is based in Beijing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 459.82M | 660.74M | 1.06B | 877.14M | 1.17B | 448.51M | 167.39M |
| Cost of Revenue | 454.78M | 734.97M | 1.13B | 968.07M | 1.37B | 663.61M | 0.00 |
| Gross Profit | 5.04M | -74.23M | -76.55M | -90.93M | -202.03M | -215.10M | 167.39M |
| Gross Profit Ratio | 1.10% | -11.23% | -7.24% | -10.37% | -17.31% | -47.96% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 101.12M | 108.01M | 376.42M | 320.20M | 181.58M | 118.80M | 93.15M |
| Selling & Marketing | 13.80M | 27.11M | 61.67M | 47.06M | 75.84M | 44.78M | 24.69M |
| SG&A | 114.92M | 135.12M | 438.09M | 367.26M | 272.55M | 183.75M | 141.91M |
| Other Expenses | 19.64M | 20.33M | -19.26M | 30.39M | -242.96M | -11.72M | 0.00 |
| Operating Expenses | 134.56M | 964.98M | 3.21B | 1.37B | 1.96B | 903.25M | 555.46M |
| Cost & Expenses | 589.34M | 964.98M | 3.21B | 1.37B | 1.96B | 903.25M | 555.46M |
| Interest Income | 1.15M | 17.08M | 3.26M | 12.86M | 10.40M | 11.67M | 15.25M |
| Interest Expense | 0.00 | 0.00 | 3.26M | 12.86M | 10.40M | 0.00 | 0.00 |
| Depreciation & Amortization | 80.66M | 186.69M | 195.16M | 247.29M | 408.11M | 369.15M | 284.93M |
| EBITDA | -20.65M | -16.33M | -312.13M | -196.97M | -381.74M | -28.66M | -70.76M |
| EBITDA Ratio | -4.49% | -12.28% | -139.70% | -3.13% | -26.70% | -6.39% | -42.27% |
| Operating Income | -129.52M | -209.35M | -514.64M | -458.20M | -474.58M | -398.85M | -284.93M |
| Operating Income Ratio | -28.17% | -31.68% | -48.67% | -52.24% | -40.65% | -88.93% | -170.22% |
| Total Other Income/Expenses | 113.18M | 32.58M | -31.55M | -10.38M | -96.10M | 13.83M | 27.06M |
| Income Before Tax | -16.34M | -321.32M | -2.16B | -505.08M | -801.80M | -443.07M | -372.82M |
| Income Before Tax Ratio | -3.55% | -48.63% | -204.10% | -57.58% | -68.69% | -98.79% | -222.72% |
| Income Tax Expense | 6.22M | 1.18M | 4.48M | 2.86M | 4.87M | 2.09M | 61.00K |
| Net Income | -4.86M | -291.67M | -2.00B | -488.49M | -791.15M | -429.59M | -355.75M |
| Net Income Ratio | -1.06% | -44.14% | -188.78% | -55.69% | -67.77% | -95.78% | -212.52% |
| EPS | -8.99 | -794.12 | -5.55K | -1.80K | -3.79K | -1.14K | -942.06 |
| EPS Diluted | -8.99 | -794.12 | -5.55K | -1.80K | -3.79K | -1.14K | -941.91 |
| Weighted Avg Shares Out | 540.84K | 367.29K | 359.42K | 271.42K | 208.64K | 377.69K | 377.63K |
| Weighted Avg Shares Out (Dil) | 540.84K | 367.29K | 359.42K | 271.42K | 208.64K | 377.69K | 377.69K |
Ucommune (UK) Stock Sees Significant Drop Amid Market Volatility
Ucommune International Ltd. (UK, Financial), a provider of flexible office spaces, experienced a notable stock decline of 5.15%.
Endace Recognized With 18 Industry Awards in H1 2024
AUCKLAND, New Zealand & AUSTIN, Texas--(BUSINESS WIRE)-- #endace--Packet capture authority Endace today announced a record haul of 18 awards during the first half of 2024. The company and its products have been honored by Cloud Computing Magazine, Cyber Defense Magazine...
Garrett Oliver Unites Brewing Industry in Pioneering 'Brewing for Impact' Initiative
BROOKLYN, N.Y.--(BUSINESS WIRE)--For over three decades Garrett Oliver, the James Beard Award Winning Brewmaster of Brooklyn Brewery, has continued to be a beacon of innovation in the craft beer movement, skillfully blending his passion for crafting exceptional beers with a...
Ucommune Regains Compliance with Nasdaq Minimum Bid Price Requirement
BEIJING , Dec. 15, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), an office space manager and provider in China, today announced that it received a notification letter (the "Notification Letter on Compliance") from the Listing...
Joining Hands Towards a Shared Future----Signing Ceremony of Strategic Cooperation Between Ucommune and New World Development (Wuhan) Limited & Forum on Optimizing Building Economy and Collaborating for Breakthrough Development Successfully Held
BEIJING , Dec. 14, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), an office space manager and provider in China, today announced that the signing ceremony of strategic cooperation between Ucommune and New World Development (Wuhan)...
Ucommune Announces Extraordinary General Meeting Results and Share Consolidation
BEIJING, Nov. 29, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), a leading co-working office space manager and provider in China, today announced that at an extraordinary general meeting of the Company held at 10 A.M. on...
Ucommune and Plateno Hotel: A Powerhouse Partnership Set to Transform the Hotel and Co-working Space
BEIJING , Oct. 24, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), a leading co-working office space manager and provider in China, today announced that it entered into a strategic cooperation agreement with Plateno Hotel Management...
Ucommune Announces Extraordinary General Meeting
BEIJING , Oct. 13, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), a leading agile office space manager and provider in China, today announced that an extraordinary general meeting of the Company (the "Meeting") will be...
Ucommune Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
BEIJING , July 24, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), a leading agile office space manager and provider in China, today announced that it received written notification (the "Notification Letter") from the Nasdaq Stock Market...
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
Source: https://incomestatements.info
Category: Stock Reports